The RSI Oscillator for AKYA moved out of oversold territory on December 06, 2024. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 26 similar instances when the indicator left oversold territory. In of the 26 cases the stock moved higher. This puts the odds of a move higher at .
The Momentum Indicator moved above the 0 level on December 06, 2024. You may want to consider a long position or call options on AKYA as a result. In of 73 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for AKYA just turned positive on December 09, 2024. Looking at past instances where AKYA's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where AKYA advanced for three days, in of 185 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 40 cases where AKYA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The 10-day moving average for AKYA crossed bearishly below the 50-day moving average on November 20, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AKYA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
AKYA broke above its upper Bollinger Band on December 10, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.167) is normal, around the industry mean (23.300). P/E Ratio (0.000) is within average values for comparable stocks, (83.485). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (2.097) is also within normal values, averaging (43.338).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AKYA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AKYA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
Industry MedicalSpecialties
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GSRIX | 12.45 | 0.11 | +0.89% |
Goldman Sachs Rising Dividend Gr Inv | |||
CGREX | 8.80 | 0.06 | +0.69% |
Invesco Global Real Estate C | |||
NMVLX | 12.32 | 0.04 | +0.33% |
Nuance Mid Cap Value Institutional | |||
JHIGX | 27.23 | N/A | N/A |
JHancock International Growth R2 | |||
NIORX | 13.05 | -0.01 | -0.08% |
Neuberger Berman Intl Small Cap R6 |
A.I.dvisor indicates that over the last year, AKYA has been loosely correlated with MXCT. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if AKYA jumps, then MXCT could also see price increases.
Ticker / NAME | Correlation To AKYA | 1D Price Change % | ||
---|---|---|---|---|
AKYA | 100% | +2.12% | ||
MXCT - AKYA | 36% Loosely correlated | +1.23% | ||
IRMD - AKYA | 34% Loosely correlated | +0.26% | ||
NOTV - AKYA | 31% Poorly correlated | +14.97% | ||
VMD - AKYA | 30% Poorly correlated | +2.17% | ||
VCYT - AKYA | 30% Poorly correlated | +0.46% | ||
More |